ECG tech coming to the Apple Watch with Kardia Band
AliveCor, have today announced the availability of Kardia Band, the world’s smallest single lead medical grade ECG. The band’s technology works with an app that is FDA cleared, meaning the data is highly accurate and much more reliable than the tech you see in most wearables today.
Kardia Band works with Apple Watch to provide a medical grade ECG and to identify possible atrial fibrillation, which is a leading cause of stroke in the UK. Artrial fibrillation is a leading cause of stroke in the UK. In fact, people over the age of 40 have a one in four lifetime risk of developing it, which leads to a 500 percent increased risk of stroke.
The Kardia Band provides a tool to analyse heart rhythm with a quick touch of the watch strap and can reveal instantly if it is normal or possible AFib.
Dr. Matthew Fay, a GP in Bradford who has been using the AliveCor Kardia technology at his practice, estimates it has reduced appointments related to palpitations and atrial fibrillation by 50 percent:
This technology saves appointments because we’re making a diagnosis in a single step.
Trudie Lobban MBE, Founder and CEO of Arrhythmia Alliance has welcomed the news of the Kardia Band:
Wearing a medical grade ECG on your wrist will ultimately help towards earlier detection and treatment of potentially fatal heart rhythm disorders.
Kardia Band operates directly with Apple Watch via the FDA-cleared Kardia Mobile app (downloadable from the App Store) and can sync heart rhythm analysis with other devices such as an iPad or iPhone. Results can also be directly shared with a healthcare professional.
The AliveCor Kardia Band is available to pre-order here and costs £199.A previous version of this article stated the Kardia Band is FDA cleared. It is not. However, it works with Kardia Mobile, which is FDA cleared.